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SUMMARY 
Serum acetylcholinesterase activity was measured in hospitalized 30 schizophrenic and 30 de-
pressive patients. It was observed that the enzyme activity was significantly higher in depressive patient 
than controls (Comprising of 20 surgical subjects). An increase in activity with the duration of illness was 
also noted in such patients. In contrast, schizophrenics did not show any significant increase except a little 
increase along with the number of episodes on comparison with control subjects. In view of the cholinergic 
predominance in depression it is suggested that increased serum cholinesterase activity in the aforementioned 
disorder may be due to a biochemical defence against the stress of higher acetylcholine content in the body 
fluids. 
A large number of reports are available 
which indicate an alteration in cholinergic 
function in psychotic disorders. In search 
of a noninvasive in vivo biological index for 
the state of cholinegic function, several 
workers recorded an increase in cholines-
terase activity vis a vis depression and schi-
zophrenic patients (Gal, 1963; Gastaldo & 
Colucci D'Amato, 1964; Kaczvnski et al., 
1964 and Murovich, 1966). However, a 
few reports present contradictory data to 
the above (Plum, 1960 and Ellman & 
Callaway, 1961). Though the research 
work exploring acetylcholinestersse acti-
vity in psychotic disorders has been in-
conclusive, yet the reported alterations 
keep on generating interest among in-
vestigators. The present work is 
aimed at studying the activity of enzyme 
acetylcholinesterase in schizophrenic and 
depressive patients. 
MATERIAL AND METHOD 
The cases for the present study consisted 
of 30 schizophrenics, 30 depressives (ex-
perimental group) and of 20 surgical sub-
jects (control group). The diagnosis of 
experimental group was based on the criteria 
proposed by Feighner et al. (1972). The 
age ranged between 17-50 years and body 
weight 45 kilograms or more. Those with 
physical illness, pregnancv, mental retarda-
tion (Primary or Secondary) or history of 
intake of drugs, e.g. immunosuppressives, an-
tipsychotics, antidepressants and lithium 
and /or addicting drugs in past three months 
were not included as these psychoactive 
dmgs may modify the cholinergic activity. 
For controls, surgical patients between 17-
50 yeais of age and with bodv weignt 45 
Kgs. or more were taken up who were not 
having any family and past history of neiro-
psychiatric illness. These patients were 
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having non-infective, ncn-degenerative and 
ron-neoplastic minor surgical problems, 
viz., hernia, haemorrhoids eic. 
These patients were kept drug free for 
two weeks from the date of hospitalization, 
all of them received unif rm hospital diet 
and only pnenobarbitone was rdministered 
if and wnen required durirg the washout 
period. 3.0 ml of venous blood was collec-
ted and serum was separated at d acetyl-
cholinesterase activity was measured by 
the method as described bv Dela Huerga 
et. al. (195'2). The data was analysed by 
using WilcoAan-Mann-Whuney 'U' test. 
RESULTS 
In the experimental and control 
group, majority of the subjects were male, 
Hindu and married. Almost equal number 
of them hailed from rural and urban areas. 
The mean body weight was above 50 
kilograms and they all were in the age 
range of 17-50 years as predecided, with 
mean for schizophrenics—31.8^7.3, for 
depressives—40.5 ±7.7, and for surgical 
controls —33.7 ±7.4. The serum ace-
tylcholinesterase enzyme activity in 
patients of depression was found to be 
significantly increased when compared 
with schizophrenic patients, and surgical 
controls, whereas, no significant difference 
was observed between schizophrenics and 
controls (Table 1). 
TABLE 1—Activity of Serum Acetylcholinesterase 
m Depression and Schizophrenia 
Patients 
Groups 
Depression 
vs 
Surgical Control 
Depression 
vs 
Schizophrenia 
N 
(30) 
(30) 
(30) 
(30) 
Mean 
(l.V.I 
ml) 
4.5 
2.7 
4.5 
2.76 
'U' 
Sta- P 
tistics 
5.2 <0.001 
6.4 < 0.001 
A positive relationship was noted in 
the activity of serum acetylcholinesterase 
and duration of illness (time from onset of 
first episode till the day of present investi-
gation). The enzyme activity was found 
to be increased in depressives wi'h 1-5 
years duration as compared to patients with 
less than 1 year duration. Schizophrenic 
patients showed no alteration of enzyme 
activity with respect to duration of illnes? 
(Table 2). 
Regarding the relationship of enzyme 
activity with the number of episodes it was 
found that enzyme activity registers a rise 
with increasing number of episodes in 
schizophrenia ; but significant increase 
was observed only when patients with 3 
or mere episodes were compared with 
patients with I or II episodes of Schizophre-
nia (Table 2). In case of patients of de-
pression, there was no relationship between 
the enzyme activity and number of episodes. 
DISCUSSION 
The results reveal that the schizophre-
nics do not have an increased serum acetyl-
cholinesterase activity. Although this 
does not preclude the absence of a possible 
imbalance in cer.tral cholinergic function 
in these patients, as it was observed that a 
slight increment in the enzyme activity with 
the number of episodes was there. These 
results are ir contrast to the earlier obser-
vations of Gal (1963), Castalde & 
Golucci D'Amato (1964), Kaczynski 
et al. (1964) and Parveen et al. (1970) who 
reported an increment in the cbolinesterase 
with some variance in schizophrenia pa-
tients. Castaldo & Colucci D'Amato also 
failed to note any relationship between 
enzyme activity and severity of the disease-
In the present work a partial degree of re-
lationship was noted in enzyme activity and 
the number of episodes. 
The acetylcholinesterase in the serum 
of patients of depression was found to be 
significantly higher when compared to con-SERUM ACETYLCHOLINESTERASE ACTIVITY  293 
TABLE 2. Activity of Acetylcholinesterase in Depression and Scizophrenia Patients vis a vis 
Duration of illness and number of Episodes* 
EPISODE 
DURATION 
<I 
vs 
II 
<I 
vs 
III or >III 
II 
vs 
III or >III 
1 Year 
vs 
< 1-5 Years 
1 Year 
vs 
>5 years 
1—5 Years 
vs 
>5 year 
N 
(12) 
(9) 
(12) 
(9) 
(9) 
(9) 
(12) 
(15) 
(12) 
(3) 
(15) 
(3) 
Depression 
Mean 
IU/ 
ml 
3.4 
4.8 
4.3 
4.8 
4.8 
4.8 
4.3 
4.6 
4.3 
4.3 
4.6 
4.3 
U 
Sta-
tistics 
1.3 
1.3 
0.1 
2.3 
** 
** 
P 
>0.05 
>0.05 
>0.05 
<0.05 
— 
— 
N 
(14) 
(7) 
(14) 
(9) 
(7) 
(9) 
(12) 
(8) 
(12) 
(9) 
(8) 
(9) 
Schizophrenia 
Mean 
IU/ 
ml 
2.6 
2.7 
2.6 
3.1 
2.7 
3.1 
2.8 
2.8 
2.8 
2.6 
2.8 
2.6 
U 
Sta-
tistics 
0.7 
2.0 
2.0 
0.9 
0.4 
1.8 
P 
>0.05 
<0.05 
^ 0.05 
>0.05 
>0.05 
>0.05 
*—Number of clear cut exacerbations during entire period of life till the present investigation including the 
present one, retrospectively meeting the criteria of Feighner et at. (1972). 
**—These groups were not compared due to small sample size in the corresponding group. 
trol subjects. Since, these patients were 
drug free prior to investigation, such incre-
ment in the enzyme activity appears to be 
related solely to their illness. 
This increased activity may reflect the 
involvement of the cential cholinergic sys-
tem in these disorders, which is claimed so 
since long (Growdon et al., 1978 ; Barbeau, 
1978). A suggestion of a presence of a 
factor responsible for an increase in the 
cholinesterase activity in the body fhid 
(including CSF) seems plausible. Hanin 
et d. (1980) have reported a substantial 
increase in erythrocyte choline level with no 
change in plasma choline content in de-
presed patients. This may be due to the 
increased hydrolysis of acetylcholine by an 
increased enzyme activity as found in the 
present report. If it is presumed, as also 
suggested by Jonowsky et al. (1972) that de-
pression is due to a cholinergic predomi-
nance, it is tempting to speculate that the 
higher release of acetylcholine in nerve 
endings which is later released in blood (and 
or also other body fluids) may trigger a de-
fence mechanism in the body against the 
neurotransmitter induced physiological 
stress, is responsible for the increased activity 294  S. C. TIWARI rt al. 
of the enzyme. The present study points 
in this direction which needs to be substan-
tiated in further studies. 
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